drugset / Trial / NCT03621657
The GRAFT Study: Gut RecolonizAtion by Fecal Transplantation
Phase 2
Completed
1 enrolled
University of Wisconsin, Madison
Agency for Healthcare Research and Quality (AHRQ) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The primary objective of this study is to compare the gut microbiota and clinical outcomes of oral FMT during antibiotic treatment, immediately following antibiotic treatment, and placebo. The second objective is to assess the safety and feasibility of daily oral Fecal Microbiome Transplant (FMT) as a treatment option.
Timeline
- Start
- 2019-03-21
- Primary completion
- 2020-02-27
- Completion
- 2020-02-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fecal Microbiome Transplant | Unknown | — | Oral |